Curated News
By: NewsRamp Editorial Staff
May 07, 2025
INBS Disrupts Drug Screening Market with Non-Invasive Fingerprint Analysis
TLDR
- INBS offers disruptive drug screening solution, tapping into $14.9B market; poised for rapid growth and transformation.
- INBS utilizes Intelligent Fingerprinting system for non-invasive drug testing, with rapid on-site results and cost efficiency.
- INBS aims to enhance drug testing by reducing biohazardous waste, improving privacy, and providing quick results, promoting workplace safety.
- INBS revolutionizes drug screening with innovative fingerprint sweat analysis, changing traditional testing methods in a cost-effective and hygienic way.
Impact - Why it Matters
This news matters as it highlights a groundbreaking technology that could transform drug testing in various industries. The development of a more efficient and hygienic drug screening process could lead to improved workplace safety and operational efficiency, impacting both employers and employees.
Summary
Intelligent Bio Solutions (NASDAQ: INBS) is revolutionizing drug screening with its non-invasive Intelligent Fingerprinting system, targeting workplace substances like opiates and cocaine. The company's innovative approach offers rapid on-site results, lower costs, and higher convenience compared to traditional methods, with an impending U.S. product launch in 2025.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, INBS Disrupts Drug Screening Market with Non-Invasive Fingerprint Analysis
